Affinity Asset Advisors, LLC Curis Inc Call Options Transaction History

Affinity Asset Advisors, LLC

2 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q4 2021 Feb 11, 2022	BUY	$4.45 - $8.09 $3.56 Million - $6.47 Million	800,000 Added 320.0%	1,050,000 $5 Million
Q1 2021 May 14, 2021	BUY	$8.78 - $12.8 $2.2 Million - $3.2 Million	250,000 New	250,000 $2.83 Million

Ticker CRIS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,814,704
Market Cap $393M
Description
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...

Get notified when there are updates to the investment portfolio of Affinity Asset Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Affinity Asset Advisors, LLC with notifications on news.